Arturo Ciccullo (A Ciccullo)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Topics

Men Who Have Sex With Men

Antiretroviral Therapy

Hepatitis C Virus

Coronavirus Disease

Top Venues

Journal of medical virology

The Journal of antimicrobial chemotherapy

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Pierluigi Francesco Salvo, Arturo Ciccullo, Valentina Iannone, Rebecca Jo Steiner, Francesco Lamanna, Rosa Anna Passerotto, Andrea Carbone, Alberto Borghetti, Simona Di Giambenedetto, Gianmaria Baldin
Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Alberto Borghetti, Arturo Ciccullo, Francesca Lombardi, Diana Giannarelli, Rosa Anna Passerotto, Francesco Lamanna, Antonella Carcagnì, Damiano Farinacci, Alex Dusina, Gianmaria Baldin, Maurizio Zazzi, Simona Di Giambenedetto
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed. Open forum infectious diseases 11 (5) (2024)
Arturo Ciccullo, Valentina Iannone, Francesca Lombardi, Alberto Borghetti, Simona Di Giambenedetto
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report. AIDS research and human retroviruses (2024)
Alberto Borghetti, Arturo Ciccullo, Francesca Lombardi, Diana Giannarelli, Rosa Anna Passerotto, Francesco Lamanna, Antonella Carcagnì, Damiano Farinacci, Alex Dusina, Gianmaria Baldin, Maurizio Zazzi, Simona Di Giambenedetto
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed. Open forum infectious diseases 11 (5) (2024)
Pierluigi Francesco Salvo, Arturo Ciccullo, Valentina Iannone, Rebecca Jo Steiner, Francesco Lamanna, Rosa Anna Passerotto, Andrea Carbone, Alberto Borghetti, Simona Di Giambenedetto, Gianmaria Baldin
Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Francesca Lombardi, Alessia Sanfilippo, Massimiliano Fabbiani, Alberto Borghetti, Arturo Ciccullo, Enrica Tamburrini, Simona Di Giambenedetto
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study. The Journal of antimicrobial chemotherapy (2023)
Angelo Roberto Raccagni, Davide Leoni, Arturo Ciccullo, Stefano Verdenelli, Anna Maria Cattelan, Simona Di Giambenedetto, Marco Falcone, Davide Mileto, Antonella Castagna, Silvia Nozza
Rapid improvement of severe Mpox lesions with oral tecovirimat. Journal of medical virology 95 (6) (2023)
Valentina Iannone, Arturo Ciccullo, Damiano Farinacci, Alberto Borghetti, Elena Visconti, Simona Marchetti, Maurizio Sanguinetti, Enrica Tamburrini, Simona Di Giambenedetto
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report. Journal of medical virology 95 (2) (2023)
Filippo Lagi, Andrea Giacomelli, Vanni Borghi, Arturo Ciccullo, Lucia Taramasso, Giordano Madeddu, Gabriella D'Ettorre, Andrea Giacometti, Filippo Ducci, Andrea De Vito, Rachele Pincino, Simona Di Giambenedetto, Cristina Mussini, Spinello Antinori, Gaetana Sterrantino
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study. Journal of medical virology 95 (10) (2023)
Valentina Iannone, Arturo Ciccullo, Damiano Farinacci, Alberto Borghetti, Elena Visconti, Simona Marchetti, Maurizio Sanguinetti, Enrica Tamburrini, Simona Di Giambenedetto
EARLY USE OF TECOVIRIMAT IN A YOUNG MAN WITH SEVERE MPOX SKIN LESIONS: A CASE REPORT. Journal of medical virology (2023)
Arturo Ciccullo, Gianmaria Baldin, Gaetana Sterrantino, Giordano Madeddu, Gabriella D'ettorre, Cristina Mussini, Simona Di Giambenedetto
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study. The Journal of antimicrobial chemotherapy (2023)
Valentina Delle Donne, Valentina Massaroni, Alberto Borghetti, Arturo Ciccullo, Alex Dusina, Francesca Lombardi, Rebecca Jo Steiner, Valentina Iannone, Pierluigi Francesco Salvo, Simona Di Giambenedetto
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic. Psychology, health & medicine (2023)
Pierluigi Francesco Salvo, Arturo Ciccullo, Valentina Iannone, Rebecca Jo Steiner, Francesco Lamanna, Rosa Anna Passerotto, Andrea Carbone, Alberto Borghetti, Simona Di Giambenedetto, Gianmaria Baldin
Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy. The Journal of antimicrobial chemotherapy (2023)
Valentina Iannone, Arturo Ciccullo, Damiano Farinacci, Alberto Borghetti, Elena Visconti, Simona Marchetti, Maurizio Sanguinetti, Enrica Tamburrini, Simona Di Giambenedetto
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report. Journal of medical virology 95 (2) (2023)
Francesca Pennati, Stefano Calza, Antonio Di Biagio, Cristina Mussini, Stefano Rusconi, Stefano Bonora, Alberto Borghetti, Eugenia Quiros-Roldan, Giovanni Sarteschi, Marianna Menozzi, Micol Ferrara, Anna Celotti, Arturo Ciccullo, Vania Giacomet, Ilaria Izzo, Laura Dotta, Raffaele Badolato, Francesco Castelli, Emanuele Foca'
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study. Immunity, inflammation and disease 11 (2) (2023)
Francesca Pennati, Stefano Calza, Antonio Di Biagio, Cristina Mussini, Stefano Rusconi, Stefano Bonora, Alberto Borghetti, Eugenia Quiros-Roldan, Giovanni Sarteschi, Marianna Menozzi, Micol Ferrara, Anna Celotti, Arturo Ciccullo, Vania Giacomet, Ilaria Izzo, Laura Dotta, Raffaele Badolato, Francesco Castelli, Emanuele Foca'
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study. Immunity, inflammation and disease 11 (2) (2023)
Davide Moschese, Damiano Farinacci, Giacomo Pozza, Arturo Ciccullo, Maria Vittoria Cossu, Andrea Giacomelli, Fabio Borgonovo, Davide Mileto, Rosaria Santangelo, Enrica Tamburrini, Giuliano Rizzardini, Spinello Antinori, Simona Di Giambenedetto
Is smallpox vaccination protective against human monkeypox? Journal of medical virology (2022)
Alberto Borghetti, Damiano Farinacci, Arturo Ciccullo, Alex Dusina, Davide Moschese, Valentina Iannone, Anna D'Angelillo, Francesca Lombardi, Valentina Delle Donne, Valentina Massaroni, Elena Visconti, Enrica Tamburrini, Simona Di Giambenedetto
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice. Journal of medical virology 94 (10) (2022)
Valentina Iannone, Damiano Farinacci, Anna D'Angelillo, Alex Dusina, Francesco Lamanna, Rosanna Passerotto, Gianmaria Baldin, Elena Visconti, Enrica Tamburrini, Alberto Borghetti, Simona Di Giambenedetto, Arturo Ciccullo
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life. AIDS research and human retroviruses 38 (11) (2022)
Arturo Ciccullo, Gianmaria Baldin, V Borghi, M V Cossu, Andrea Giacomelli, F Lagi, Damiano Farinacci, V Iannone, R A Passerotto, A Capetti, Gaetana Sterrantino, C Mussini, Spinello Antinori, S Di Giambenedetto
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV. The Journal of antimicrobial chemotherapy (2022)
Francesca Lombardi, Simone Belmonti, Davide Moschese, Massimiliano Fabbiani, Alberto Borghetti, Arturo Ciccullo, Elena Visconti, Simona Di Giambenedetto
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting. HIV research & clinical practice 23 (1) (2022)
Damiano Farinacci, Arturo Ciccullo, Francesca Lombardi, Davide Moschese, Anna D'Angelillo, Valentina Iannone, Francesco Lamanna, Rosa Anna Passerotto, Simona Di Giambenedetto
Evaluation of doravirine-based regimen population target in a large Italian clinical center. Antiviral therapy 26 (3-5) (2021)
Massimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, Letizia Oreni, Filippo Lagi, Luigi Celani, Manuela Colafigli, Andrea De Vito, Mazzitelli Maria, Alex Dusina, Miriam Durante, Francesca Montagnani, Stefano Rusconi, Amedeo Capetti, Gaetana Sterrantino, Gabriella D'Ettorre, Simona Di Giambenedetto, null null
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort. HIV medicine 22 (9) (2021)
Arturo Ciccullo, Gianmaria Baldin, Cristina Putaggio, Simona Di Giambenedetto, Alberto Borghetti
Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV. Expert opinion on drug safety 20 (11) (2021)
Arturo Ciccullo, Gianmaria Baldin, Alberto Borghetti, Simona Di Giambenedetto
Real-life findings on the impact of the COVID-19 pandemic on HIV care. Antiviral therapy 26 (3-5) (2021)
Filippo Lagi, Annarita Botta, Arturo Ciccullo, Chiara Picarelli, Massimiliano Fabbiani, Simona di Giambenedetto, Vanni Borghi, Cristina Mussini, Alessandro Bartoloni, Gaetana Sterrantino
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study. HIV research & clinical practice 22 (4) (2021)
Alberto Borghetti, Andrea Giacomelli, Vanni Borghi, Arturo Ciccullo, Alex Dusina, Massimiliano Fabbiani, Stefano Rusconi, Maurizio Zazzi, Cristina Mussini, Simona Di Giambenedetto
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice. Open forum infectious diseases 8 (7) (2021)
Alberto Borghetti, Arturo Ciccullo, Elena Visconti, Enrica Tamburrini, Simona Di Giambenedetto
COVID-19 diagnosis does not rule out other concomitant diseases. European journal of clinical investigation 50 (6) (2020)
Arturo Ciccullo, Gianmaria Baldin, Alberto Borghetti, Simona Di Giambenedetto
Dolutegravir plus lamivudine for the treatment of HIV-1 infection. Expert review of anti-infective therapy 18 (4) (2020)
Alberto Borghetti, Arturo Ciccullo, F Lombardi, Gianmaria Baldin, Simone Belmonti, M Prosperi, F Incardona, E Heger, V Borghi, A Sönnerborg, M Zazzi, A De Luca, S Di Giambenedetto
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors. HIV medicine 22 (1) (2020)
Arturo Ciccullo, Alberto Borghetti, A Dusina, F V Segala, E Visconti, E Tamburrini, R Cauda, S Di Giambenedetto
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic. HIV medicine 22 (1) (2020)
Manuela Colafigli, Arturo Ciccullo, Alberto Borghetti, Iuri Fanti, Federico Melis, Sara Modica, Ilaria Uccella, Antonio Bonadies, Virginia Ferraresi, Enza Anzalone, Alfredo Pennica, Emilia Migliano, Barbara Rossetti, Giordano Madeddu, Roberto Cauda, Antonio Cristaudo, Simona Di Giambenedetto, Alessandra Latini
Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort Experience. Journal of clinical medicine 8 (12) (2019)
Arturo Ciccullo, Gabriele Giuliano, Francesco Vladimiro Segala, Eleonora Taddei, Damiano Farinacci, Federico Pallavicini
Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection. Infection 48 (2) (2019)
Arianna Emiliozzi, Arturo Ciccullo, Alberto Borghetti, Chiara Picarelli, Damiano Farinacci, Gianmaria Baldin, Simona Di Giambenedetto
'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice. HIV medicine 21 (2) (2019)
Alberto Borghetti, D Moschese, A Cingolani, Gianmaria Baldin, D Speziale, Arturo Ciccullo, F Lombardi, Arianna Emiliozzi, Simone Belmonti, A Antinori, R Cauda, S Di Giambenedetto
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure. HIV medicine 20 (9) (2019)
Francesca Lombardi, Simone Belmonti, Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Roberto Cauda, Massimiliano Fabbiani, Simona Di Giambenedetto
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients. HIV research & clinical practice (2019)
Alberto Borghetti, G Baldin, F Lombardi, Arturo Ciccullo, A Capetti, S Rusconi, G Sterrantino, A Latini, M V Cossu, R Gagliardini, A De Luca, S Di Giambenedetto
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication. HIV medicine (2018)
Gianmaria Baldin, Arturo Ciccullo, A Capetti, S Rusconi, Gaetana Sterrantino, M V Cossu, Andrea Giacomelli, F Lagi, A Latini, P Bagella, A De Luca, S Di Giambenedetto, Giordano Madeddu
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study. HIV medicine 20 (2) (2018)
Arturo Ciccullo, R Gagliardini, G Baldin, A Borghetti, D Moschese, A Emiliozzi, F Lombardi, R Ricci, D Speziale, F Pallavicini, S Di Giambenedetto
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy. HIV medicine 19 (6) (2018)
Arturo Ciccullo, F R Ponziani, E Maiolo, F Pallavicini, M Pompili
Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report. Infection 47 (2) (2018)